Exact Mass: 261.0624
Exact Mass Matches: 261.0624
Found 405 metabolites which its exact mass value is equals to given mass value 261.0624,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Oxolinic acid
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 3609 CONFIDENCE standard compound; INTERNAL_ID 1034 D004791 - Enzyme Inhibitors
Imazapyr
CONFIDENCE standard compound; INTERNAL_ID 2630 D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals
O-Phosphotyrosine
O-Phosphotyrosine is a phosphorylated amino acid that occurs in a number of proteins. Tyrosine phosphorylation and dephosphorylation plays a role in cellular signal transduction and possibly in cell growth control and carcinogenesis. Small amounts of free phosphotyrosine can be found in urine (PMID: 7693088). Levels of this amino acid appear to be elevated in mammalian urine during liver regeneration (PMID: 7516161). Phosphotyrosine is also able to induce platelet aggregation in vitro and it has been suggested that free phosphotyrosine in blood could be meaningful for in vivo platelet activation (PMID: 1282059). [HMDB] O-Phosphotyrosine is a phosphorylated amino acid that occurs in a number of proteins. Tyrosine phosphorylation and dephosphorylation plays a role in cellular signal transduction and possibly in cell growth control and carcinogenesis. Small amounts of free phosphotyrosine can be found in urine (PMID: 7693088). Levels of this amino acid appear to be elevated in mammalian urine during liver regeneration (PMID: 7516161). Phosphotyrosine is also able to induce platelet aggregation in vitro and it has been suggested that free phosphotyrosine in blood could be meaningful for in vivo platelet activation (PMID: 1282059).
Aminoparathion
Aminoparathion is a highly reactive metabolite of parathion. A highly reactive metabolite of parathion [HMDB]
NS-102
NS-102 is a selective kainate (GluK2) receptor antagonist. NS-102 is a potent GluR6/7 receptor antagonist[1][2][3].
flumequine
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors CONFIDENCE standard compound; INTERNAL_ID 1030 CONFIDENCE standard compound; INTERNAL_ID 8533 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3642
Flumequine
Ciprofloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria. It functions by inhibiting DNA gyrase, a type II topoisomerase, and topoisomerase IV, enzymes necessary to separate bacterial DNA, thereby inhibiting cell division. Flumequine is a 9-fluoro-6,7-dihydro-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid. The molecular formula is C14H12FNO3 It is a white powder, odorless, flavorless, insoluble in water but soluble in organic solvent. Flumequine is a synthetic chemotherapeutic antibiotic of the fluoroquinolone drug class used to treat bacterial infections. It is a first-generation fluoroquinolone antibacterial that has been removed from clinical use and is no longer being marketed. It kills bacteria by interfering with the enzymes that cause DNA to unwind and duplicate. Flumequine was used in veterinarian medicine for the treatment of enteric infections (all infections of the intestinal tract), as well as to treat cattle, swine, chickens, and fish, but only in a limited number of countries. It was occasionally used in France (and a few other European Countries) to treat urinary tract infections under the trade name Apurone. However this was a limited indication because only minimal serum levels were achieved. The first quinolone used was nalidixic acid (was marketed in many countries as Negram) followed by the fluoroquinolone flumequine. The first-generation fluoroquinolone agents, such as flumequine, had poor distribution into the body tissues and limited activity. As such they were used mainly for treatment of urinary tract infections. Flumequine (benzo quinolizine) was first patented in 1973, (German Patent) by Rikker Labs. Flumequine is a known antimicrobial compound described and claimed in U.S. Pat. No. 3,896,131 (Example 3), July 22, 1975. Flumequine is the first quinolone compound with a fluorine atom at the C6-position of the related quinolone basic molecular structure. Even though this was the first fluoroquinolone, it is oftentimes overlooked when classifying the drugs within this class by generations and excluded from such a list. There continues to be considerable debate as to whether or not this DNA damage is to be considered one of the mechanisms of action concerning the severe adverse reactions experienced by some patients following fluoroquinolone therapy. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors
Glycyl-Tryptophan
Glycyl-Tryptophan is a dipeptide composed of glycine and tryptophan. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Dihydromaleimide beta-D-glucoside
Dihydromaleimide beta-D-glucoside is found in pulses. Dihydromaleimide beta-D-glucoside is an alkaloid from Pisum sativum (peas Alkaloid from Pisum sativum (peas). Dihydromaleimide beta-D-glucoside is found in pulses and common pea.
Pisatoside
Isolated from seedlings of Pisum sativum (peas). Pisatoside is found in pulses and common pea. Pisatoside is found in pulses. Pisatoside is isolated from seedlings of Pisum sativum (peas).
gamma-Glutamylasparagine
gamma-Glutamylasparagine is a dipeptide composed of gamma-glutamate and asparagine, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. gamma-Glutamylasparagine is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Asparaginylglutamic acid
Asparaginylglutamic acid is a dipeptide composed of asparagine and glutamic acid. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Glutamylasparagine
Glutamylasparagine is a dipeptide composed of glutamate and asparagine, and is a proteolytic breakdown product of larger proteins. It belongs to the family of N-acyl-alpha amino acids and derivatives. These are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. Glutamylasparagine is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Aspartyl-Glutamine
Aspartyl-Glutamine is a dipeptide composed of aspartate and glutamine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Glutaminylaspartic acid
Glutaminylaspartic acid is a dipeptide composed of glutamine and aspartic acid. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis.
Tryptophyl-Glycine
Tryptophyl-Glycine is a dipeptide composed of tryptophan and glycine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Tolfenamic acid
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AG - Fenamates Tolfenamic acid (TA) is one of the class of non-steroidal anti-inflammatory drugs (NSAIDs). It is used to treat the symptoms of migraine. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D011448 - Prostaglandin Antagonists C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000700 - Analgesics D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
Dehydrogenated ticlopidine
Dehydrogenated ticlopidine is only found in individuals that have used or taken Ticlopidine. Dehydrogenated ticlopidine is a metabolite of Ticlopidine. Dehydrogenated ticlopidine belongs to the family of Thienopyridines. These are heterocyclic compounds containing a thiophene ring fused to a pyridine ring.
Aspartyl-Gamma-glutamate
Aspartyl-Gamma-glutamate is a dipeptide composed of aspartate and gamma-glutamate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
2-Methoxyacetaminophen sulfate
2-Methoxyacetaminophen sulfate, also known as 4-(acetylamino)-3-methoxyphenyl hydrogen sulfate, is a member of the class of compounds known as phenylsulfates. Phenylsulfates are compounds containing a sulfuric acid group conjugated to a phenyl group. 2-Methoxyacetaminophen sulfate is practically insoluble (in water) and an extremely strong acidic compound (based on its pKa).
O-Sulfotyrosine
O-Sulfotyrosine belongs to the class of organic compounds known as phenylalanine and derivatives. Phenylalanine and derivatives are compounds containing phenylalanine or a derivative thereof resulting from a reaction of phenylalanine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. O-Sulfotyrosine has been identified as a potential plasma biomarker of reduced kidney function in early chronic kidney disease (CKD), end stage renal disease (ESRD), and hemodialytic clearance (PMID: 31048706). Human plasma levels of O-sulfotyrosine were reported to be influenced by genetic variants in the gene ARSA which codes for the enzyme arylsulfatase A (PMID: 24816252).
4-[2-[(Benzothiazol-2-yl)thio]ethyl]-1H-imidazole
1-beta-D-Arabinofuranosyl-5-fluorocytosine
Acetamide, N-[2-(5-methoxy-1-nitroso-1H-indol-3-yl)ethyl]-
2-Phenylpyrazolo(4,3-c)quinolin-3(5H)-one
D002491 - Central Nervous System Agents > D000697 - Central Nervous System Stimulants > D003292 - Convulsants D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018756 - GABA Antagonists D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018755 - GABA Agonists
1-(3-Methylbenzoyl)-1H-indazole-3-carbonitrile
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors
Cyclic-hpmpc
Cicletanine
C - Cardiovascular system > C03 - Diuretics > C03B - Low-ceiling diuretics, excl. thiazides D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic D045283 - Natriuretic Agents > D004232 - Diuretics
Dehydroxymethylepoxyquinomicin
2,6-Diamino-3,5-dihydro-7-(3-thienylmethyl)-4H-pyrrolo(3,2-d)pyrimidin-4-one
(4S)-4-Amino-1,3-dioxohexane-1,2,6-tricarboxylic acid
N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]-N-nitrosoacetamide
3-(4-chlorobenzyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-ol
3-Amino-4-(tert-butyl)thieno[2,3-b]thiophene-2,5-dicarbonitrile
Annomontine
An alkaloid that is beta-carboline substituted at position C-1 by a 2-aminopyrimidin-4-yl moiety. An antiparasitic agent found in Annona montana and Annona foteida.
N-Ac,Tri-Me ester-(R)-2-Amino-1,1,2-ethanetricarboxylic acid|N-Ac,Tri-Me ester-(??)-2-Amino-1,1,2-ethanetricarboxylic acid
5-(1H-Indol-3-yl)-5-methoxy-4-thioxoimidazolidin-2-one
2-aceto-3-amino-5-hydroxy-6-methoxy-1,4-naphthoquinone|goniothalaminone B
2-[[2-[(2-aminoacetyl)amino]acetyl]amino]pentanedioic acid
Tryptophylglycine
relative retention time with respect to 9-anthracene Carboxylic Acid is 0.056 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.392
tolfenamic acid
M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AG - Fenamates D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D011448 - Prostaglandin Antagonists C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000700 - Analgesics D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
Gly-Trp
A dipeptide formed from glycine and L-tryptophan residues.
Tris(2-hydroxyethyl) isocyanurate
CONFIDENCE standard compound; INTERNAL_ID 582; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2494; ORIGINAL_PRECURSOR_SCAN_NO 2492 CONFIDENCE standard compound; INTERNAL_ID 582; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2502; ORIGINAL_PRECURSOR_SCAN_NO 2499 CONFIDENCE standard compound; INTERNAL_ID 582; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2512; ORIGINAL_PRECURSOR_SCAN_NO 2508 CONFIDENCE standard compound; INTERNAL_ID 582; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2513; ORIGINAL_PRECURSOR_SCAN_NO 2510 CONFIDENCE standard compound; INTERNAL_ID 582; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2505; ORIGINAL_PRECURSOR_SCAN_NO 2504
ETHYL 1-BENZYL-3-HYDROXY- 2-OXO[5H]PYRROLE-4-CARBOXYLATE
TRP-Gly
A dipeptide formed from L-tryptophan and glycine residues.
Isosuccinimide b-D-glucoside
Sulfamide, [2-hydroxy-5-[(3-hydroxypropyl)amino]phenyl]- (9CI)
2-AMINO-4-(4-ETHYLPHENYL)THIOPHENE-3-CARBOXYLICACIDMETHYLESTER
8-ACETYL-6-METHOXY-7-METHYL-6H-[1,2,5]OXADIAZOLO[3,4-E]INDOLE 3-OXIDE
5-Fluorocytidine
5-Fluorocytidine is a member of cytidines, inhibits maturation of the 45S ribosomal RNA precursor[1].
ethyl 2-amino-4-(4-methylphenyl)thiophene-3-carboxylate
methyl 2-amino-5-ethyl-4-phenylthiophene-3-carboxylate
4-Allyl-5-(4-methoxy-benzyl)-4H-[1,2,4]triazole-3-thiol
3-Chloro-2-(3-methyl-5-(trifluoromethyl)-1H-pyrazol-1-yl)pyridine
6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2-benzothiazole
1,2,4-Triazin-5(2H)-one,3,4-dihydro-2-b-D-ribofuranosyl-3-thioxo-
Ethanamine, 2-(4-bromo-2-fluorophenoxy)-N,N-dimethyl
2-(1,3-dioxoisoindol-2-yl)-4-methyl-pentanoic acid
2-(3,5-DIMETHYL-PHENYL)-THIAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
2-[(6-Chloro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]benzonitrile
3-AMINO-3-(5,7-DIMETHYL-4-OXO-4H-CHROMEN-3-YL)-PROPIONIC ACID
6-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)-hexanoic
2-CHLORO-1-[2,5-DIMETHYL-1-(4-METHYLPHENYL)-1H-PYRROL-3-YL]-1-ETHANONE
Tricaine methanesulfonate
D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics
2-(6-Methyl-4,8-dioxo-1,3,6,2-dioxazaborocan-2-yl)benzaldehyde
3-(6-Methyl-4,8-dioxo-1,3,6,2-dioxazaborocan-2-yl)benzaldehyde
5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thieno[2,3-b]pyridine
2-chloro-5-(3,5-dimethylphenyl)pyridine-3-carboxylic acid
4-(4-chloro-phenoxy)-cyclohexylamine hydrochloride
5-CHLORO-8-METHYL-2-(TRIFLUOROMETHYL)QUINOLIN-4-OL
7-CHLORO-8-METHYL-2-(TRIFLUOROMETHYL)QUINOLIN-4-OL
2-AMINO-4-(3,4-DIMETHYLPHENYL)THIOPHENE-3-CARBOXYLICACIDMETHYLESTER
6-(4-METHANESULFONYL-PHENYL)-PYRIDINE-3-CARBALDEHYDE
ethyl 2-(3-ethylphenyl)-1,3-thiazole-4-carboxylate
4-[(4-methoxyphenyl)amino]benzenediazonium chloride
5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]thiazole
7-Ethoxycarbonylindole-2-carboxylic acid ethyl ester
2-[3-[(4-nitrophenyl)methyl]imidazol-4-yl]acetic acid
(2-AMINO-4-METHYL-PHENYL)-CARBAMICACIDTERT-BUTYLESTER
4-Chloro-3-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)pyridine hydrochloride
3-Phenyl-3-(2,2,2-trifluoroacetamido)propanoic Acid
4-Amino-1-(2-chloro-4-fluorobenzyl)pyrazole Hydrochloride
3-Quinolinecarboxylic acid, 1-ethyl-1,2-dihydro-4-hydroxy-2-oxo-, ethyl ester
4-(4,4-Dimethyl-2,6-dioxo-1-piperidinyl)benzoic acid
methyl 2-[5-methyl-2-(4-methylphenyl)-1,3-thiazol-4-yl]acetate
4-chloro-1-(6-methoxypyridin-2-yl)pyrazolo[3,4-d]pyrimidine
2-(3,4-DIMETHYL-PHENYL)-THIAZOLE-4-CARBOXYLIC ACID ETHYL ESTER
4-CHLORO-7-(2-FURYLMETHYL)-5,6-DIMETHYL-7H-PYRROLO[2,3-D]PYRIMIDINE
2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzothiazole
Ancitabine hydrochloride
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite D009676 - Noxae > D000963 - Antimetabolites D000970 - Antineoplastic Agents Ancitabine (hydrochloride) is an important antileukemia drugs.
2-(2,3-dihydro-1-benzofuran-5-yl)-4-methyl-1,3-thiazole-5-carboxylic acid
4-[(2-ETHOXY-3,4-DIOXOCYCLOBUT-1-ENYL)AMINO]BENZOIC ACID
1H-Pyrrole-2,5-dione,1-[2-(3,4-dimethoxyphenyl)ethyl]-
N-(1,3-Dioxo-2,8-diazaspiro[4.5]dec-2-yl)acetamide hydrochloride (1:1)
5,6-DIHYDRO-1,3(2H)-PYRIDINEDICARBOXYLIC ACID, 3-METHYL 1-PHENYL ESTER
3-(Pyrrolidin-1-ylsulfonyl)thiophene-2-carboxylic acid
Benzenamine,2-methyl-4-[2-(2-methylphenyl)diazenyl]-, hydrochloride (1:1)
Butanoic acid,4-oxo-4-[[3-(trifluoromethyl)phenyl]amino]-
2-AMINO-5-METHYL-4-P-TOLYL-THIOPHENE-3-CARBOXYLIC ACID METHYL ESTER
2-(1,3-DIOXO-1,3-DIHYDRO-2H-ISOINDOL-2-YL)-3-METHYLPENTANOIC ACID
Ethyl 5-amino-1-(4-methoxyphenyl)-1H-pyrazole-4-carboxylate
(2-Oxo-2,3,5,6-tetrahydrospiro[indole-3,4-pyran]-1(2H)-yl)ac etic acid
ETHYL 2-(3,5-DICHLOROPHENYL)THIAZOLE-4-CARBOXYLATE
1-THIOPHEN-2-YLMETHYL-PIPERIDINE-3-CARBOXYLIC ACID HYDROCHLORIDE
(3,4-difluorophenyl)-piperidin-4-ylmethanone,hydrochloride
ETHYL 8-HYDROXY-[1,3]DIOXOLO[4,5-G]QUINOLINE-7-CARBOXYLATE
2-[4-(2,5-dimethylpyrrol-1-yl)phenyl]sulfanylacetic acid
[(1-Isopropyl-1H-benzimidazol-2-yl)methyl]amine dihydrochloride
methyl (E)-3-(4-fluorophenyl)-2-(1,2,4-triazol-1-ylmethyl)prop-2-enoate
methyl 2-[(4-fluorophenyl)-(1,2,4-triazol-1-yl)methyl]prop-2-enoate
5-Chloro-10-methylpyrimido[4,5-b]quinoline-2,4(3H,10H)-dione
ethyl 6-hydroxy-7-methylpyrrolo[2,3-g][2,1,3]benzoxadiazole-8-carboxylate
1-(TERT-BUTOXYCARBONYL)-1H-INDOLE-5-CARBOXYLIC ACID
4-ALLYL-5-[(4-METHYLPHENOXY)METHYL]-4H-1,2,4-TRIAZOLE-3-THIOL
4-CHLORO-6-(METHYLSULFANYL)-2-PHENYL-5-PYRIMIDINECARBONITRILE
1,4,5,6-TETRAHYDRO-2-METHYL-6-OXO-4-[4-(METHOXY)PHENYL]-3-PYRIDINECARBOXYLIC ACID
4-tert-butyl 3-methyl thiomorpholine-3,4-dicarboxylate
tert-butyl 4-bromo-5,6-dihydropyridine-1(2H)-carboxylate
(4-CHLORO-PHENYL)-(5-HYDROXY-CYCLOPENT-1-ENYL)-METHANONE
(2-Chloro-pyridin-4-yl)-piperazin-1-yl-Methanone hydrochloride
8-(3-forMylphenyl)-4-Methyl-2,6-dioxohexahydro-[1,3,2]oxazaborolo[2,3-b][1,3,2]oxazaborol-4-iuM-8-uide
phenyl (2-fluoro-4-(hydroxymethyl)phenyl)carbamate
3-[(3-methylphenoxy)methyl]-4-prop-2-enyl-1H-1,2,4-triazole-5-thione
6-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZO[D]THIAZOLE
2-(2-Thienyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one
(3S,4R)-4-(4-chlorophenyl)pyrrolidine-3-carboxylic acid
Ethyl 2-amino-4-methyl-5-phenylthiophene-3-carboxylate
5-(Furan-2-yl)-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazole-1-carboxamide
2-(4-chlorophenyl)-3a,4,7,7a-tetrahydroisoindole-1,3-dione
boc-(r)-5,5-dimethylthiazolidine-4-carboxylic acid
METHYL 2,3-DIMETHYL-8-OXO-5,6,7,8-TETRAHYDRO-1-OXA-7A-AZAINDACENE-4-CARBOXYLATE
2-hydroxy-N-(2-hydroxy-5-oxo-7-oxabicyclo[4.1.0]hept-3-en-3-yl)benzamide
1-Benzyl-4-hydroxy-5-oxo-2,5-dihydro-1H-pyrrole-3-carboxylic acid ethyl ester
2-Thiophenecarboxylic acid (4-acetamidophenyl) ester
3-(4,8-Dimethyl-quinolin-2-ylsulfanyl)-propionic acid
6-(4-Chlorophenyl)-2-methyl-3-pyridinecarboxylic acid methyl ester
(4R)-3-tert-Butoxycarbonyl-2,2-dimethylthiazolidine-4-carboxylic acid
N-(5-Isopropyl-thiazol-2-YL)-2-pyridin-3-YL-acetamide
3-[({(1e)-[2-(Trifluoromethyl)phenyl]methylidene}amino)oxy]propanoic Acid
[2-Aminomethyl-5-Oxo-4-(4-Oxo-Cyclohexa-2,5-Dienylmethyl)-4,5-Dihydro-Imidazol-1-Yl]-Acetaldehyde
oxolinic acid
A quinolinemonocarboxylic acid having the carboxy group at position 7 as well as oxo- and ethyl groups at positions 4 and 1 respectively and a dioxolo ring fused at the 5- and 6-positions. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D004791 - Enzyme Inhibitors
Cicletanine
C - Cardiovascular system > C03 - Diuretics > C03B - Low-ceiling diuretics, excl. thiazides D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic D045283 - Natriuretic Agents > D004232 - Diuretics
2-[(5-Amino-1-hydroxy-1-oxopentan-2-yl)amino]pentanedioic acid
(2S)-2-[(2-azaniumylacetyl)amino]-3-(1H-indol-3-yl)propanoate
Ala-Asp-Gly
A tripeptide composed of L-alanine, L-aspartic acid, and glycine units joined in sequence by peptide linkages.
3-(3,5-Dimethyl-1-pyrazolyl)-1,2-benzothiazole 1,1-dioxide
3-(4-Chlorophenyl)-6-(1-pyrrolidinyl)-1,2,4,5-tetrazine
5-(methoxymethyl)-2-thiophen-2-yl-1H-pyrazolo[1,5-a]pyrimidin-7-one
2-Hydroxy-5-[[(5-methyl-2-furanyl)-oxomethyl]amino]benzoic acid
3-ethyl-2-sulfanylidene-6,7,8,9-tetrahydro-1H-pyrimido[4,5-b]quinolin-4-one
5-Ethoxy-2-[(prop-2-enylamino)methylidene]-1-benzothiophen-3-one
4-methyl-N-[sulfanylidene-(1,2,4-triazol-4-ylamino)methyl]benzamide
5-(4-Morpholinyl)-2-thiophen-2-yl-4-oxazolecarbonitrile
5-[(2-Cyanoethylthio)methyl]-2-benzofurancarboxylic acid
(4-Hydroxy-2-oxo-1,2-dihydro-quinolin-3-yl)-acetic acid propyl ester
2-(4-Chloro-2-methylanilino)-3-pyridinecarboxamide
2-(7-Methyl-4-oxo-3-furo[3,4]pyrrolo[3,5-c][1,2,4]triazinyl)acetic acid methyl ester
5-[(3,6-dideoxy-alpha-L-arabino-hexopyranosyl)oxy]-3-oxopentanoate
(4R)-4-[(2S,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-oxopentanoate
Aminoparathion
An organic thiophosphate that is 4-aminophenol in which the hydroxy group is replaced by a (diethoxyphosphorothioyl)oxy group. It is a metabolite of parathion.
O(4)-sulfo-L-tyrosine
An O-sulfoamino acid that is L-tyrosine in which the phenolic hydrogen has been replaced by a sulfo group.
2-Methoxyacetaminophen sulfate
A member of the class of acetamides that is paracetamol sulfate substituted by a methoxy group at position 3.
O(4)-phospho-L-tyrosine
A non-proteinogenic L-alpha-amino acid that is L-tyrosine phosphorylated at the phenolic hydroxy group.
2-deoxy-5,6-dihydroxy-5,6-dihydrocytidine
A nucleoside analogue that is the 5,6-dihydroxy-5,6-dihydro derivative of cytidine. It is a metabolite produced by the bacterium Mycoplasma genitalium.
Ancitabin hydrochloride
Ancitabine (hydrochloride) is an important antileukemia drugs.
Etilevodopa (hydrochloride)
Etilevodopa (L-Dopa ethyl ester) hydrochloride, an ethyl-ester proagent of Levodopa, is rapidly hydrolyzed to Levodopa and ethanol by nonspecific esterases in the gastrointestinal tract. Etilevodopa hydrochloride is used for the treatment of Parkinson disease (PD). Levodopa is the direct precursor of dopamine and is a suitable proagent as it facilitates CNS penetration and delivers dopamine[1][2][3].
